These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7039882)

  • 1. Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.
    Knight SC; Harding B; Burman S; Mertin J
    Clin Exp Immunol; 1981 Oct; 46(1):61-9. PubMed ID: 7039882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J
    Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patients.
    Knight SC; Abbosh J; Lance EM
    Postgrad Med J; 1976; 52(5 Suppl):131-5. PubMed ID: 995783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
    Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
    Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.
    Gonzalez RL; Dau PC; Spitler LE
    Clin Exp Immunol; 1979 Apr; 36(1):78-84. PubMed ID: 313860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal T cell subsets and lymphocyte activity in multiple sclerosis.
    Albala MM; Davignon D; Fast LD; Clark DD
    Clin Exp Immunol; 1985 Sep; 61(3):542-7. PubMed ID: 3878242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G; Coustans M
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
    Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
    Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy.
    de Vere-Tyndall A; Knight S; Burman S; Denman AM; Ansell BM
    Clin Exp Immunol; 1982 Dec; 50(3):549-54. PubMed ID: 7165998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis.
    Trotter JL; Clifford DB; McInnis JE; Griffeth RC; Bruns KA; Perlmutter MS; Anderson CB; Collins KG; Banks G; Hicks BC
    Ann Neurol; 1989 Feb; 25(2):172-8. PubMed ID: 2521993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
    Neuhaus O; Wiendl H; Kieseier BC; Archelos JJ; Hemmer B; Stüve O; Hartung HP
    J Neuroimmunol; 2005 Nov; 168(1-2):128-37. PubMed ID: 16171875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy.
    Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Luciani G; Ranelletti FO; Castagneto M; Piantelli M
    Clin Exp Immunol; 1984 Jan; 55(1):217-23. PubMed ID: 6362935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
    ten Berge RJ; van Walbeek HK; Schellekens PT
    Clin Exp Immunol; 1982 Dec; 50(3):495-502. PubMed ID: 7165996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS).
    Kosmaczewska A; Bilinska M; Ciszak L; Noga L; Pawlak E; Szteblich A; Podemski R; Frydecka I
    J Neuroimmunol; 2007 Sep; 189(1-2):137-46. PubMed ID: 17669511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I; Yaron R; Oluwole SF; Hardy MA
    Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
    Warabi Y; Yagi K; Hayashi H; Matsumoto Y
    J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
    Mar P; Gradl T; Dörner C; Contag I
    Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.